ArticleCureus2026
Assessment of Mucormycetes in Subgingival Plaque of Periodontitis and Non-periodontitis Patients: An In Vivo Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Periodontitis is a chronic inflammatory disease associated with dysbiotic microbial biofilms. Fungi may also play a role in exacerbating periodontal disease, especially in immunocompromised individuals, where opportunistic infections such as mucormycosis are associated with high morbidity and mortality rates. While mucormycosis occasionally manifests orally, its presence in subgingival plaque, a potential microbial reservoir, remains unexplored. This study investigates whether immunocompetent individuals with periodontitis are at risk for mucormycosis. Methods Subgingival plaque was collected from 10 patients with Stage II or III periodontitis and 10 age-matched non-periodontitis controls (aged 18-60 years) at Amrita School of Dentistry's Department of Periodontics. Exclusion criteria encompassed systemic diseases, recent antibiotic or antifungal use, smoking, pregnancy, and antiseptic mouthwash use within three months. Samples were obtained using sterile Gracey curettes, stored in saline-filled cryovials, and cultured on Sabouraud Dextrose Agar (SDA) at 30°C for 48 hours. Fungal growth was microscopically evaluated for mucormycetes using lactophenol cotton blue staining. The proportion of positive cultures was compared between groups via Pearson's chi-square test. Results None of the samples (n = 20) were identified as containing mucormycetes in either group. No statistics were computed because mucormycosis was constant. Conclusion This study found no evidence of mucormycetes in subgingival plaque, indicating that it may not be a common niche in immunocompetent individuals. Larger studies in immunocompromised individuals using molecular approaches are recommended to elucidate fungal roles in periodontal contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.